Furthermore, topical application of the PPARβ/δ antagonist GSK0660 prevented UV-dependent Src stimulation; and the expression of PPARβ/δ positively correlated with the expression of SRC and EMT markers in human skin squamous cell carcinoma (SCC) highlighting the clinical relevance of these findings [42]. This evidence concerns the gene SRC and skin squamous cell carcinoma.